Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons so they can concentrate on providing the best patient care. Integra focuses on regenerative medicine, and among its product portfolio is SurgiMend®, a biologic acellular dermal matrix for soft tissue reinforcement. Indicated for Plastic and Reconstructive Surgery, the SurgiMend® PRS portfolio of products are derived from fetal bovine dermis, rich in Type III collagen. The collagen matrix rehydrates in a few minutes and is easy to handle. SurgiMend® PRS comes in multiple shapes and sizes, including both fenestrated and meshed configurations to address sub-pectoral and pre-pectoral needs.